Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.94 |
High Similarity |
NPD6234 |
Discontinued |
0.9139 |
High Similarity |
NPD4966 |
Approved |
0.9139 |
High Similarity |
NPD4967 |
Phase 2 |
0.9139 |
High Similarity |
NPD4965 |
Approved |
0.8981 |
High Similarity |
NPD7228 |
Approved |
0.894 |
High Similarity |
NPD37 |
Approved |
0.8662 |
High Similarity |
NPD7199 |
Phase 2 |
0.8553 |
High Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.8485 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.8415 |
Intermediate Similarity |
NPD7240 |
Approved |
0.8411 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.8247 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.8171 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8138 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8063 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8011 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.795 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7857 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7833 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7824 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.78 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7798 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7765 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7764 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7751 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7736 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7718 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7716 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7716 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7711 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7708 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7679 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7669 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7662 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7635 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7628 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7628 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7616 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7602 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7584 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.758 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7566 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7558 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7558 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7515 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7515 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7514 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7827 |
Phase 1 |
0.7483 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.747 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7438 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7438 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7423 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7415 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7405 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7386 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7384 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7381 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7375 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7365 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7365 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7365 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7351 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7324 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7297 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7296 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7296 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7294 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7289 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7289 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7285 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7284 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7278 |
Intermediate Similarity |
NPD7296 |
Approved |
0.7267 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7267 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7263 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7261 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7261 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7261 |
Intermediate Similarity |
NPD6100 |
Approved |
0.726 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7255 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7255 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7251 |
Intermediate Similarity |
NPD5242 |
Approved |
0.723 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7212 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7212 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7211 |
Intermediate Similarity |
NPD17 |
Approved |
0.7208 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.72 |
Intermediate Similarity |
NPD1283 |
Approved |
0.719 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7188 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7186 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD5563 |
Clinical (unspecified phase) |
0.7184 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7183 |
Intermediate Similarity |
NPD228 |
Approved |
0.7171 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7169 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7161 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7152 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7151 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7135 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7126 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7125 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7118 |
Intermediate Similarity |
NPD919 |
Approved |
0.7107 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7107 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7107 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7101 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7097 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7093 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7089 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.707 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7067 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7066 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7063 |
Intermediate Similarity |
NPD5958 |
Discontinued |
0.7051 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7051 |
Intermediate Similarity |
NPD943 |
Approved |
0.7051 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7048 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7044 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7042 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7042 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7041 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7032 |
Intermediate Similarity |
NPD3268 |
Approved |
0.703 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7025 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7021 |
Intermediate Similarity |
NPD5005 |
Approved |
0.7021 |
Intermediate Similarity |
NPD5006 |
Approved |
0.702 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7012 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7007 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7006 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6995 |
Remote Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD5647 |
Approved |
0.6983 |
Remote Similarity |
NPD7280 |
Phase 3 |
0.6983 |
Remote Similarity |
NPD8312 |
Approved |
0.6983 |
Remote Similarity |
NPD7281 |
Phase 3 |
0.6983 |
Remote Similarity |
NPD8313 |
Approved |
0.6982 |
Remote Similarity |
NPD2978 |
Approved |
0.6982 |
Remote Similarity |
NPD2977 |
Approved |
0.6981 |
Remote Similarity |
NPD3748 |
Approved |
0.6981 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6964 |
Remote Similarity |
NPD6386 |
Approved |
0.6964 |
Remote Similarity |
NPD6385 |
Approved |
0.6962 |
Remote Similarity |
NPD1607 |
Approved |
0.6959 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.6959 |
Remote Similarity |
NPD3749 |
Approved |
0.6959 |
Remote Similarity |
NPD1894 |
Discontinued |
0.6959 |
Remote Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD4534 |
Discontinued |
0.6957 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6948 |
Remote Similarity |
NPD2861 |
Phase 2 |
0.6933 |
Remote Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD3847 |
Discontinued |
0.6932 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6923 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.6913 |
Remote Similarity |
NPD5585 |
Approved |
0.6909 |
Remote Similarity |
NPD5401 |
Approved |
0.6898 |
Remote Similarity |
NPD4420 |
Approved |
0.6897 |
Remote Similarity |
NPD5711 |
Approved |
0.6897 |
Remote Similarity |
NPD5710 |
Approved |
0.6894 |
Remote Similarity |
NPD5763 |
Approved |
0.6894 |
Remote Similarity |
NPD5762 |
Approved |
0.6887 |
Remote Similarity |
NPD1091 |
Approved |
0.6887 |
Remote Similarity |
NPD1535 |
Discovery |
0.6883 |
Remote Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD6663 |
Approved |
0.6879 |
Remote Similarity |
NPD6746 |
Phase 2 |
0.6875 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6867 |
Remote Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.686 |
Remote Similarity |
NPD6971 |
Discontinued |
0.6859 |
Remote Similarity |
NPD4625 |
Phase 3 |
0.6845 |
Remote Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.6845 |
Remote Similarity |
NPD4005 |
Discontinued |
0.6845 |
Remote Similarity |
NPD3455 |
Phase 2 |
0.6845
|
Remote Similarity |
NPD6723 |
Discontinued |